Joint Research Office
- Home
- What does the JRO do?
- Approvals
- Post Approval
- Academic Clinical Trials
- Commercial Research
- Biostatistics
- Training and Education
- Patient and Public Involvement
- Funding Opportunities
- JRO News
- Standard Operating Procedures
© Irene Aspalter
Clinical Trials of Investigational Medicinal Products (CTIMPs)
The Joint Research Office (JRO) is the UCL Office responsible for supporting and overseeing investigator-initiated Clinical Trials of Investigational Medicinal Products (CTIMPs).
The JRO has a dedicated
clinical trials team who are on hand to provide regulatory advice, monitoring
support and oversight, as well as guidance on
pharmacovigilance and the sourcing, management and handling of Investigational
Medicinal Products.
What is a CTIMP?
A Clinical Trial of
an Investigational Medicinal Product (CTIMP) is any investigation in human
subjects intended to:
·discover or verify the clinical, pharmacological effects of one or more medicinal products
or
·identify any adverse reactions to one or more such products
or
·study absorption, distribution, metabolism and excretion of the product with the aim of looking at the safety or efficacy of those products.
The item investigated could be a drug or food product and is called the IMP - the Investigational Medicinal Product
